| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.0022 | 1 |